Asundexian (SUNHARBO) — Drug Intelligence Dossier
A medicinal-chemistry dossier on asundexian (SUNHARBO) — the first approved Factor XIa inhibitor: mechanism, the originator CuAAC/Suzuki route and its chiral-pool patent-avoiding alternative, key intermediates, and the OCEANIC-STROKE data.
Read article →